Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07452354) titled 'AI-Based Diabetic Foot Recurrence Cohort' on Feb. 28.

Study Type: Observational [Patient Registry]

Primary Sponsor: Peking University Third Hospital

Condition: Diabetic Foot Ulcer (DFU) Diabete Mellitus Diabetic Foot Ulcer Treatment Artificial Intelligence (AI) in Diagnosis

Intervention: Diagnostic Test: Researchers predefined groups based on risk stratification to formulate personalized follow-up strategies.

Recruitment Status: Not recruiting

Date of First Enrollment: March 15, 2026

Target Sample Size: 200

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07452354 ...